🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is looking at outcomes in people with advanced cancers who have ...
Status
Terminated
Location
Peter MacCallum Cancer Centre
Start Date
2021-09-23
Trial ID
NCT04801966
The purpose of this study is to test the safety of a new medication, Olapar...
Status
Completed
Location
Baptist Alliance Miami Cancer Institute
Start Date
2018-07-12
Trial ID
NCT03532880
Single arm, single site, open-label Phase II study of the effects of oral o...
Status
Recruiting
Location
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Start Date
2019-06-03
Trial ID
NCT03786796
Treatments Being Tested
The purpose of this research study is to evaluate the effectiveness of usin...
Status
Active Not Recruiting
Location
Indiana University Simon Comprehensive Cancer Center
Start Date
2022-09-02
Trial ID
NCT05366166
Treatments Being Tested
This study will evaluate the efficacy and safety of olaparib (MK-7339) mono...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus ( Site 0011)
Start Date
2018-12-12
Trial ID
NCT03742895
Treatments Being Tested
Around 15-25% of ovarian cancer (OC) patients carry germ-line mutation in B...
Status
Unknown
Location
Fondazione Policlinico Gemelli IRCCS
Start Date
2019-12-01
Trial ID
NCT04261465
Treatments Being Tested
Evaluation of the efficacy of the combination of olaparib and trabectedin i...
Status
Completed
Location
Medizinische Fakultät der TU Dresden
Start Date
2018-10-25
Trial ID
NCT03127215
Treatments Being Tested
The goal of this prospective, phase IV, multi-centre clinical trial is to t...
Status
Active Not Recruiting
Location
Azienda Socio Sanitaria Territoriale (ASST) Lariana
Start Date
2023-09-15
Trial ID
NCT06121401
Treatments Being Tested
This is a Phase II, non-randomized, open-label study to evaluate temozolomi...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2020-06-17
Trial ID
NCT04166435
Treatments Being Tested
This biomarker study has been designed to assess the effects of different a...
Status
Completed
Location
Research Site
Start Date
2017-09-18
Trial ID
NCT03022409
Treatments Being Tested